Balaxi Pharmaceuticals Share Price

NSE
BALAXI •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Balaxi Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
27.19% Fall from 52W High
-11.2
TTM PE Ratio
Below industry Median
13.4
Price to Book Ratio
Above industry Median
3
Dividend yield 1yr %
0
TTM PEG Ratio
0

Balaxi Pharmaceuticals Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Jun 2024 - 65.6215 Cr Mar 2024 - 238.6479 Cr
Mar 2024 - 59.8331 Cr Mar 2023 - 339.0696 Cr
Dec 2023 - 60.785 Cr Mar 2022 - 284.3595 Cr
Sep 2023 - 54.7209 Cr Mar 2021 - 233.5605 Cr
Jun 2023 - 65.9554 Cr Mar 2020 - 48.4437 Cr
Net Profit/Loss
QuarterlyYearly
Jun 2024 - 6.4804 Cr Mar 2024 - -2.3869 Cr
Mar 2024 - 10.9338 Cr Mar 2023 - 45.9625 Cr
Dec 2023 - 13.5936 Cr Mar 2022 - 47.6578 Cr
Sep 2023 - 14.4286 Cr Mar 2021 - 38.1374 Cr
Jun 2023 - -41.343 Cr Mar 2020 - 6.104 Cr

Balaxi Pharmaceuticals Ltd shareholding Pattern

Promoter
66%
Foreign Institutions
16.9%
Public
17.1%
Promoter
66.9%
Foreign Institutions
17.2%
Public
15.9%
Promoter
71.2%
Foreign Institutions
18.6%
Public
10.2%
Promoter
71.2%
Foreign Institutions
18.6%
Public
10.2%
Promoter
71.2%
Foreign Institutions
18.6%
Public
10.2%
Promoter
71.6%
Foreign Institutions
18.7%
Public
9.7%

Balaxi Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
110.30
10Day EMA
109.70
12Day EMA
109.50
20Day EMA
109.60
26Day EMA
109.90
50Day EMA
111.50
100Day EMA
112.20
200Day EMA
109.60
5Day SMA
111.20
10Day SMA
109.10
20Day SMA
108.80
30Day SMA
109.60
50Day SMA
111.10
100Day SMA
116.60
150Day SMA
115.00
200Day SMA
107.80
Delivery & Volume
Day
Combined Delivery Volume- 22742 Rs
NSE+BSE Traded Volume- 49010 Rs

Week
Combined Delivery Volume- 66038 Rs
NSE+BSE Traded Volume- 205816 Rs

Month
Combined Delivery Volume- 24210 Rs
NSE+BSE Traded Volume- 68527 Rs

Resistance & Support
111.63
Pivot
Resistance
First Resistance
113.65
Second Resistance
117.03
Third Resistance
119.05
Support
First Support
108.25
Second support
106.23
Third Support
102.85
Relative Strength Index
50.69
Money Flow Index
77.26
MACD
-0.34
MACD Signal
-0.95
Average True Range
6.04
Average Directional Index
30.20
Rate of Change (21)
1.67
Rate of Change (125)
8.43

Balaxi Pharmaceuticals Ltd Company background

Founded in: 1942
Balaxi Ventures Limited was formerly incorporated in the name of The Anandam Rubber Company Limited on September 28, 1942. The Company changed its name from The Anandam Rubber Company Limited to Balaxi Ventures Limited on August 08, 2017. The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 201819 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%).The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders hardware on August 08, 2018. The Company commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG products from Financial Year 201819.Further, in February 2019, it kickstarted Food Products business by launching a range of biscuits under the brand YAP.The Company expanded its presence by establishing a central distribution warehouse in Guatemala, marking its entry into the third geography. This expansion helped in strengthening the distribution network and a wider customer base in 2019. In FY 2023, Company started operations in two Latin American Countries, i.e., Honduras and El Salvador and also started operations inthe Central African Republic.
Read More

Balaxi Pharmaceuticals Ltd FAQs

The past 1-year return of Balaxi Pharmaceuticals Ltd [BALAXI] share was 21.72. The Balaxi Pharmaceuticals Ltd [BALAXI] share hit a 1-year low of Rs. 79.99 and a 1-year high of Rs. 151.45.

The market cap of Balaxi Pharmaceuticals Ltd is Rs. 608.77 Cr. as of 9/12/2024 12:00:00 AM.

The PE ratios of Balaxi Pharmaceuticals Ltd is 245.04 as of 9/12/2024 12:00:00 AM.

The PB ratios of Balaxi Pharmaceuticals Ltd is 4.89 as of 9/12/2024 12:00:00 AM

You can easily buy Balaxi Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -